Sinocare Inc., a leading player in the medical device industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a pioneer in diabetes management solutions, focusing on innovative blood glucose monitoring systems and related healthcare products. Sinocare's core offerings include advanced glucose meters, test strips, and diabetes management software, all designed to enhance patient care and improve health outcomes. What sets Sinocare apart is its commitment to accuracy, affordability, and user-friendly technology, making diabetes management accessible to a broader audience. With a strong market presence, Sinocare has achieved significant milestones, including numerous certifications and awards for its products. The company continues to expand its influence in the healthcare sector, striving to empower individuals with diabetes through reliable and effective monitoring solutions.
How does Sinocare Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sinocare Inc.'s score of 22 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sinocare Inc., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Sinocare Inc. may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. As a result, the company’s climate commitments and initiatives remain unclear, and it appears that there are no inherited emissions data or targets from a parent or related organization. Without specific emissions data or reduction initiatives, it is challenging to assess Sinocare Inc.'s impact on climate change or its alignment with industry standards for sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sinocare Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
